FAST FIVE: Another 60MM J&J Doses Produced At Troubled Baltimore Plant Are Tainted, FDA Says

Published by on

Another 60MM J&J Doses Produced At Troubled Baltimore Plant Are Tainted, FDA Says Readers may remember earlier this year when an accident at the Emergent Biosolutions lab in Baltimore led to millions of J&J and AstraZeneca doses being ruined (after workers cross-contaminated them with ingredients from AstraZeneca jabs being produced in the same factory).

But despite the US government handing over control to J&J, attempts to re-start production have been in limbo, and according to the NYT, another 60MM doses produced at the facility didn't meet the agency's safety standards.

But the latest production hiccup will make it more difficult for the US to export doses to countries around the world in desperate need of them.

Regulators have the discretion to take that action if the drugs are badly needed and in short supply, they said.

For weeks now, the FDA has been trying to figure out what to do about at least 170MM doses of the vaccine that were left in limbo after the discovery of the production mishap mentioned above.

Categories: ZH